Related Experiment Video
Updated: Aug 20, 2025
08:25
Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
6.8K
Genotoxicity testing of nanomaterials
Robert Landsiedel1,2, Naveed Honarvar1, Svenja Berit Seiffert3
1Experimental Toxicology and Ecology, BASF SE, Ludwigshafen am Rhein, Germany.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology
|November 23, 2022
Summary
Genotoxicity testing for nanomaterials is difficult due to their unique properties. This review evaluates current methods, recommending specific assays for DNA and chromosome damage, and highlights future research needs for reliable nanotoxicity assessment.
Area of Science:
- Toxicology of Nanomaterials
- Regulatory Issues in Nanomedicine
Background:
- Nanomaterials offer unique properties but pose potential health risks.
- Traditional genotoxicity tests are often unsuitable for nanomaterials without modification.
Purpose of the Study:
- To critically review existing genotoxicity assays for nanomaterial assessment.
- To identify challenges and propose strategies for adapting these tests.
Main Methods:
- Examination of DNA damage assays (e.g., comet assay).
- Evaluation of gene mutation assays (e.g., mouse lymphoma assay, hprt assay).
- Assessment of chromosome mutation assays (e.g., micronucleus test, chromosome aberration test).
Main Results:
- The micronucleus test is preferred over the chromosome aberration test for chromosome mutations.
- Mammalian cell gene mutation tests are more useful than the Ames test for nanomaterials.
- Significant challenges remain in test validation and strategy development.
Conclusions:
- Adaptation of genotoxicity tests is crucial for nanomaterial safety evaluation.
- Further research is needed on reference materials, test concentrations, and system applicability.
- Defining standardized testing strategies is essential for regulatory purposes.
